NPPA issued a notification regarding the

Jan 07, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00

Industry Specific Compliance The National Pharmaceutical Pricing Authority (NPPA) on January 07, 2025, issued a notification regarding the fixation of the retail price of Aspirin IP 75 mg.

The following has been stated: -

•For each hard gelatin capsule Contains: Aspirin IP 75 mg (as Gastro-resistant tablet IP) + Atorvastatin Calcium IP eq. to Atorvastatin 40 mg for M/s Windlas Biotech Ltd. (Manufacturer) & M/s Intas Pharmaceuticals Ltd. (Marketer) the retail price is 18.27 (Rs)

[Notification No. 19(4351)/2024/DP/NPPA/DIV.III/9685/2025]

View Document 1